Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Common Equity (2020 - 2025)

LifeStance Health (LFST) has disclosed Common Equity for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 5.17% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 5.17% year-over-year, with the annual reading at $1.5 billion for FY2025, 5.17% up from the prior year.
  • Common Equity for Q4 2025 was $1.5 billion at LifeStance Health, up from $1.5 billion in the prior quarter.
  • The five-year high for Common Equity was $1.5 billion in Q4 2021, with the low at $954.0 million in Q1 2021.
  • Average Common Equity over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • The sharpest move saw Common Equity surged 61.69% in 2022, then decreased 5.91% in 2023.
  • Over 5 years, Common Equity stood at $1.5 billion in 2021, then decreased by 1.7% to $1.5 billion in 2022, then dropped by 5.91% to $1.4 billion in 2023, then increased by 1.21% to $1.4 billion in 2024, then increased by 5.17% to $1.5 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $1.5 billion, $1.5 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.